person · Reporting owner
SALEKI-GERHARDT AZITA
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AbbVie Inc.ABBV · Entity 2800 | EVP, CHIEF OPERATIONS OFFICER | February 27, 2026 | March 03, 2026 |
| ENTEGRIS INCENTG · Entity 3271 | Director | May 06, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AbbVie Inc.
Report date February 27, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 197,794 |
Reported balance
After 2026-02-27 transaction · row 1
1 source rowRow 1 · 2026-02-27 · Tax withholding · Disposed 16,309 · Balance 197,794 |
| Common Stock, $0.01 par valueSEC Table I · non-derivative | IndirectProfit sharing trust | 2,706 |
Reported balance
Holding disclosure · report date 2026-02-27 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,706 F1: Balance in AbbVie Savings program as of February 20, 2026. Balance includes shares acquired pursuant to a dividend reinvestment feature. |
| Common Stock, $0.01 par valueSEC Table I · non-derivative | IndirectBy spouse | 3,873 |
Reported balance
Holding disclosure · report date 2026-02-27 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 3,873 F2: The reporting person disclaims beneficial ownership of all securities held by her spouse. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in AbbVie Savings program as of February 20, 2026. Balance includes shares acquired pursuant to a dividend reinvestment feature.
F2: The reporting person disclaims beneficial ownership of all securities held by her spouse.
ENTEGRIS INC
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,383 |
Reported balance
After 2026-05-06 transaction · row 1
1 source rowRow 1 · 2026-05-06 · Grant · Acquired 1,412 · Balance 26,383 F1: These Restricted Stock Units vest in full on the earlier of (1) the first anniversary date of the grant, or (2) the date of the Company's 2027 Annual Meeting of Stockholders. F2: These shares were awarded on May 6, 2026 as Restricted Stock Units, payable solely in Common Stock, pursuant to the Entegris, Inc. 2020 Stock Plan, which provides for the award of Restricted Stock Units to independent directors in consideration for services as such. |
Filing footnotes · ownership attribution and instrument terms
F1: These Restricted Stock Units vest in full on the earlier of (1) the first anniversary date of the grant, or (2) the date of the Company's 2027 Annual Meeting of Stockholders.
F2: These shares were awarded on May 6, 2026 as Restricted Stock Units, payable solely in Common Stock, pursuant to the Entegris, Inc. 2020 Stock Plan, which provides for the award of Restricted Stock Units to independent directors in consideration for services as such.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2017 Filed Mar 2, 2017 23:13 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 19,096 | $62.22 | $1,188,153.12 |
DisclosureSEC source: 0001179110-17-003705 · edgar.xml · nonDerivative · entry 1 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,299 Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 22:52 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 47,870 | $0.00 Strike: $61.36 | $0.00 |
DisclosureSEC source: 0001179110-17-002813 · edgar.xml · derivative · entry 5 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,870 Underlying: Common stock · 47,870 shares Expires 2027-02-15 F5 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exercisable in annual increments of 15,957 on 02/16/2018, 15,956 on 02/16/2019, and 15,957 on 02/16/2020. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 22:52 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 7,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002813 · edgar.xml · nonDerivative · entry 2 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,395 F2 · shares: Represents shares of AbbVie common stock issued under a performance-vested restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 22:52 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 15,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002813 · edgar.xml · nonDerivative · entry 1 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,315 F1 · shares: Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on adjusted earnings per share and relative total shareholder return measures. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 22:21 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 2,400 | $0.00 Strike: $27.29 | $0.00 |
DisclosureSEC source: 0001179110-17-001675 · edgar.xml · derivative · entry 5 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 0 Underlying: Common stock · 2,400 shares Expires 2017-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 22:21 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 1,558 | $60.89 | $94,866.62 |
DisclosureSEC source: 0001179110-17-001675 · edgar.xml · nonDerivative · entry 4 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 3,873 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by her spouse. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 22:21 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 2,400 | $27.29 | $65,496.00 |
DisclosureSEC source: 0001179110-17-001675 · edgar.xml · nonDerivative · entry 3 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by her spouse. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:25 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,776 | $55.38 | $98,349.55 |
DisclosureSEC source: 0001179110-16-020684 · edgar.xml · nonDerivative · entry 2 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,579 Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:25 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 13,608 | $56.00 | $762,048.00 |
DisclosureSEC source: 0001179110-16-020684 · edgar.xml · nonDerivative · entry 1 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,355 Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 22:09 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 42,370 | $0.00 Strike: $54.86 | $0.00 |
DisclosureSEC source: 0001179110-16-019785 · edgar.xml · derivative · entry 1 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,370 Underlying: Common stock · 42,370 shares Expires 2026-02-17 F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 14,124 on 02/18/2017, 14,123 on 02/18/2018, and 14,123 on 02/18/2019. Read SEC document |
| February 05, 2016 Filed Feb 9, 2016 22:13 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 3,400 | $0.00 Strike: $22.94 | $0.00 |
DisclosureSEC source: 0001179110-16-018825 · edgar.xml · derivative · entry 5 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 0 Underlying: Common stock · 3,400 shares Expires 2016-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2016 Filed Feb 9, 2016 22:13 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 2,112 | $56.76 | $119,877.12 |
DisclosureSEC source: 0001179110-16-018825 · edgar.xml · nonDerivative · entry 4 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 3,031 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by her spouse. Read SEC document |
| February 05, 2016 Filed Feb 9, 2016 22:13 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 3,400 | $22.94 | $77,998.38 |
DisclosureSEC source: 0001179110-16-018825 · edgar.xml · nonDerivative · entry 3 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by her spouse. Read SEC document |
| February 28, 2015 Filed Mar 3, 2015 23:09 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 4,592 | $60.50 | $277,816.00 |
DisclosureSEC source: 0001179110-15-004097 · edgar.xml · nonDerivative · entry 3 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,963 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 23:09 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,112 | $60.47 | $127,706.30 |
DisclosureSEC source: 0001179110-15-004097 · edgar.xml · nonDerivative · entry 2 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,555 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 23:09 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 5,901 | $60.52 | $357,128.52 |
DisclosureSEC source: 0001179110-15-004097 · edgar.xml · nonDerivative · entry 1 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,667 Read SEC document |
| February 19, 2015 Filed Feb 23, 2015 22:12 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 52,870 | $0.00 Strike: $58.88 | $0.00 |
DisclosureSEC source: 0001179110-15-003166 · edgar.xml · derivative · entry 4 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,870 Underlying: Common stock · 52,870 shares Expires 2025-02-18 F4 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 17,624 on 02/19/2016, 17,623 on 02/19/2017, and 17,623 on 02/19/2018. Read SEC document |
| February 19, 2015 Filed Feb 23, 2015 22:12 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 26,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003166 · edgar.xml · nonDerivative · entry 1 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,568 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 09, 2015 Filed Feb 11, 2015 22:28 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 2,250 | $0.00 Strike: $24.07 | $0.00 |
DisclosureSEC source: 0001179110-15-002333 · edgar.xml · derivative · entry 5 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 0 Underlying: Common stock · 2,250 shares Expires 2015-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2015 Filed Feb 11, 2015 22:28 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 1,425 | $56.90 | $81,082.50 |
DisclosureSEC source: 0001179110-15-002333 · edgar.xml · nonDerivative · entry 4 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 1,743 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by her spouse. Read SEC document |
| February 09, 2015 Filed Feb 11, 2015 22:28 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 2,250 | $24.07 | $54,164.48 |
DisclosureSEC source: 0001179110-15-002333 · edgar.xml · nonDerivative · entry 3 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 3,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by her spouse. Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:17 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $50.26 | $5,026.40 |
DisclosureSEC source: 0001179110-14-004347 · edgar.xml · nonDerivative · entry 8 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,828 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:17 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 200 | $50.26 | $10,052.60 |
DisclosureSEC source: 0001179110-14-004347 · edgar.xml · nonDerivative · entry 7 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,928 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:17 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $50.26 | $5,026.10 |
DisclosureSEC source: 0001179110-14-004347 · edgar.xml · nonDerivative · entry 6 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,128 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:17 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $50.25 | $5,025.30 |
DisclosureSEC source: 0001179110-14-004347 · edgar.xml · nonDerivative · entry 5 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,228 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:17 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 581 | $50.25 | $29,195.25 |
DisclosureSEC source: 0001179110-14-004347 · edgar.xml · nonDerivative · entry 4 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,328 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:17 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,200 | $50.25 | $60,295.20 |
DisclosureSEC source: 0001179110-14-004347 · edgar.xml · nonDerivative · entry 3 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,909 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:17 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 162 | $50.24 | $8,138.88 |
DisclosureSEC source: 0001179110-14-004347 · edgar.xml · nonDerivative · entry 2 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,109 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:17 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 6,336 | $51.91 | $328,901.76 |
DisclosureSEC source: 0001179110-14-004347 · edgar.xml · nonDerivative · entry 1 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,271 Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 22:22 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 51,990 | $0.00 Strike: $51.42 | $0.00 |
DisclosureSEC source: 0001179110-14-003480 · edgar.xml · derivative · entry 4 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,990 Underlying: Common stock · 51,990 shares Expires 2024-02-19 F4 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 17,330 on 02/20/2015, 17,330 on 02/20/2016, and 17,330 on 02/20/2017. Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 22:22 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 30,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003480 · edgar.xml · nonDerivative · entry 1 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,607 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 10, 2014 Filed Feb 12, 2014 21:49 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 1,466 | $0.00 Strike: $45.06 | $0.00 |
DisclosureSEC source: 0001179110-14-002593 · edgar.xml · derivative · entry 5 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 1,466 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2014 Filed Feb 12, 2014 21:49 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 1,389 | $48.89 | $67,908.21 |
DisclosureSEC source: 0001179110-14-002593 · edgar.xml · nonDerivative · entry 2 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,467 Read SEC document |
| February 10, 2014 Filed Feb 12, 2014 21:49 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 1,466 | $45.06 | $66,057.96 |
DisclosureSEC source: 0001179110-14-002593 · edgar.xml · nonDerivative · entry 1 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2014 Filed Feb 7, 2014 22:08 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 387 | $47.84 | $18,512.15 |
DisclosureSEC source: 0001179110-14-002334 · edgar.xml · nonDerivative · entry 2 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,390 Read SEC document |
| February 05, 2014 Filed Feb 7, 2014 22:08 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 300 | $47.85 | $14,353.50 |
DisclosureSEC source: 0001179110-14-002334 · edgar.xml · nonDerivative · entry 1 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,777 Read SEC document |
| January 03, 2014 Filed Jan 7, 2014 22:09 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 1,626 | $51.98 | $84,519.48 |
DisclosureSEC source: 0001179110-14-000630 · edgar.xml · nonDerivative · entry 1 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,077 Read SEC document |
| December 19, 2013 Filed Dec 21, 2013 01:31 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 2,186 | $0.00 Strike: $28.41 | $0.00 |
DisclosureSEC source: 0001179110-13-018460 · edgar.xml · derivative · entry 7 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 0 Underlying: Common stock · 2,186 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 19, 2013 Filed Dec 21, 2013 01:31 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 304 | $0.00 Strike: $28.37 | $0.00 |
DisclosureSEC source: 0001179110-13-018460 · edgar.xml · derivative · entry 6 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 0 Underlying: Common stock · 304 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 19, 2013 Filed Dec 21, 2013 01:31 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 1,682 | $54.32 | $91,366.24 |
DisclosureSEC source: 0001179110-13-018460 · edgar.xml · nonDerivative · entry 5 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 918 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by her spouse. Read SEC document |
| December 19, 2013 Filed Dec 21, 2013 01:31 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 2,186 | $28.41 | $62,094.86 |
DisclosureSEC source: 0001179110-13-018460 · edgar.xml · nonDerivative · entry 4 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 2,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by her spouse. Read SEC document |
| December 19, 2013 Filed Dec 21, 2013 01:31 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 304 | $28.37 | $8,625.85 |
DisclosureSEC source: 0001179110-13-018460 · edgar.xml · nonDerivative · entry 3 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by her spouse. Read SEC document |
| September 17, 2013 Filed Sep 18, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 1,997 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001179110-13-014321 · edgar.xml · derivative · entry 13 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 1,997 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2013 Filed Sep 18, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 4,600 | $0.00 Strike: $28.86 | $0.00 |
DisclosureSEC source: 0001179110-13-014321 · edgar.xml · derivative · entry 12 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 4,600 shares Expires 2018-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2013 Filed Sep 18, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,789 | $46.48 | $83,152.72 |
DisclosureSEC source: 0001179110-13-014321 · edgar.xml · nonDerivative · entry 7 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,703 Read SEC document |
| September 17, 2013 Filed Sep 18, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 3,695 | $46.00 | $169,970.00 |
DisclosureSEC source: 0001179110-13-014321 · edgar.xml · nonDerivative · entry 6 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,492 Read SEC document |
| September 17, 2013 Filed Sep 18, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 1,997 | $37.18 | $74,248.46 |
DisclosureSEC source: 0001179110-13-014321 · edgar.xml · nonDerivative · entry 5 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2013 Filed Sep 18, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 4,600 | $28.86 | $132,768.88 |
DisclosureSEC source: 0001179110-13-014321 · edgar.xml · nonDerivative · entry 4 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2013 Filed Sep 18, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 2,200 | $0.00 Strike: $28.32 | $0.00 |
DisclosureSEC source: 0001179110-13-014321 · edgar.xml · derivative · entry 11 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 2,200 shares Expires 2018-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2013 Filed Sep 18, 2013 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 4,100 | $0.00 Strike: $27.29 | $0.00 |
DisclosureSEC source: 0001179110-13-014321 · edgar.xml · derivative · entry 10 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 4,100 shares Expires 2017-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.